Drug application
CONRAY 400 (IOTHALAMATE SODIUM)
Drugs@FDA NDA 014295 · MALLINCKRODT
Key facts
| Drug name | CONRAY 400 |
|---|---|
| Active ingredients | IOTHALAMATE SODIUM |
| Application type | NDA |
| Application number | 014295 |
| Company | MALLINCKRODT |
| Dosage forms | INJECTABLE, INJECTION |
| Strength | 66.8% |
| Marketing status | Discontinued |
| Reference listed drug | No |
| Latest submission class | Type 5 - New Formulation or New Manufacturer |
| Latest submission status date | Sep 30, 1963 |
At a glance
- 1–9 Submissions
- 10–99 Supplements
- None Label versions
- 1–9 Products
- None Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.